Rinaldi M, Della Corte M, Ruocco V, D'Onofrio C, Zanotta G, Romano A
Eye Clinic First School of Medicine, University of Naples, Italy.
Metab Pediatr Syst Ophthalmol (1985). 1993;16(1-2):23-5.
We examined 25 patients affected from Cooley's disease and five by beta-thalassemia intermedia. The mean age was 15 +/- 6.3 years. Fifteen patients, (18 years or older) three of them affected by beta-thalassemia intermedia, presented ocular abnormalities. So it was impossible to establish a correlation between laboratory data and ocular damages; their observation, with reference to untreated beta-thalassemia subjects, suggested that ocular abnormalities cannot be only attributed to desferrioxamine treatment.
我们检查了25例患有库利氏病的患者和5例中间型β地中海贫血患者。平均年龄为15±6.3岁。15名患者（18岁及以上），其中3名患有中间型β地中海贫血，出现了眼部异常。因此，无法在实验室数据和眼部损害之间建立关联；对未经治疗的β地中海贫血患者的观察表明，眼部异常不能仅归因于去铁胺治疗。
